Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Apr 11, 2023 4:05pm
104 Views
Post# 35389268

RE:early stoppage

RE:early stoppageTo be fair to Seto and Kellum, I don't believe they ever tried to sell early stoppage at interim. In fact, I remember Kellum speaking out quite strongly a couple years ago- that because of the small sample size of 150 early stoppage was not on the table.

The only place I have heard about early stoppage is from our very own MM. It is a rumor he's pushed relentlessly for years to pretend away the pace having anything to do with the timing of Tigris trial completion.

If someone can point out that the company did make this claim- I'll stand corrected. But I believe they spoke out clearly as they do not want this baseless rumor to be repeated ad nauseam.

But of course, now MM has flipped it- now implying management is misleading shareholders on this front to fill up on cheap options.. It must be so dizzying to pretend to believe management's every word, but also believe they are conspiring to lie to every shareholder to cheat out a few extra shares..
<< Previous
Bullboard Posts
Next >>